These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 11786100)

  • 1. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
    Onozato ML; Tojo A; Goto A; Fujita T; Wilcox CS
    Kidney Int; 2002 Jan; 61(1):186-94. PubMed ID: 11786100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of NADPH oxidase inhibitor in diabetic nephropathy.
    Asaba K; Tojo A; Onozato ML; Goto A; Quinn MT; Fujita T; Wilcox CS
    Kidney Int; 2005 May; 67(5):1890-8. PubMed ID: 15840036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
    Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N
    Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy.
    Onozato ML; Tojo A; Goto A; Fujita T
    Diabetes Res Clin Pract; 2003 Feb; 59(2):83-92. PubMed ID: 12560157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure.
    Tojo A; Onozato ML; Kobayashi N; Goto A; Matsuoka H; Fujita T
    Hypertension; 2002 Dec; 40(6):834-9. PubMed ID: 12468566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.
    Fan Q; Liao J; Kobayashi M; Yamashita M; Gu L; Gohda T; Suzuki Y; Wang LN; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2004 Dec; 19(12):3012-20. PubMed ID: 15574998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time observation of glomerular hemodynamic changes in diabetic rats: effects of insulin and ARB.
    Li B; Yao J; Kawamura K; Oyanagi-Tanaka Y; Hoshiyama M; Morioka T; Gejyo F; Uchiyama M; Oite T
    Kidney Int; 2004 Nov; 66(5):1939-48. PubMed ID: 15496165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species.
    Koo JR; Vaziri ND
    Kidney Int; 2003 Jan; 63(1):195-201. PubMed ID: 12472783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats.
    Tamura T; Jamous MA; Kitazato KT; Yagi K; Tada Y; Uno M; Nagahiro S
    J Hypertens; 2009 Jun; 27(6):1284-92. PubMed ID: 19307983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats.
    Palm F; Connors SG; Mendonca M; Welch WJ; Wilcox CS
    Hypertension; 2008 Feb; 51(2):345-51. PubMed ID: 18158356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic L-arginine administration increases oxidative and nitrosative stress in rat hyperoxaluric kidneys and excessive crystal deposition.
    Huang HS; Ma MC; Chen J
    Am J Physiol Renal Physiol; 2008 Aug; 295(2):F388-96. PubMed ID: 18448592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.
    Oak JH; Cai H
    Diabetes; 2007 Jan; 56(1):118-26. PubMed ID: 17192473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased aortic NADPH oxidase activity in rats with genetically high angiotensin-converting enzyme levels.
    Jalil JE; PĂ©rez A; Ocaranza MP; Bargetto J; Galaz A; Lavandero S
    Hypertension; 2005 Dec; 46(6):1362-7. PubMed ID: 16230508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide.
    Sata N; Tanaka Y; Suzuki S; Kamimura R; Mifune H; Nakamura K; Miyahara K; Arima T
    Circ J; 2003 Dec; 67(12):1053-8. PubMed ID: 14639023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet.
    Onozato ML; Tojo A; Goto A; Fujita T
    Kidney Int; 2004 Mar; 65(3):951-60. PubMed ID: 14871415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade.
    Awad AS; Webb RL; Carey RM; Siragy HM
    J Hypertens; 2004 Aug; 22(8):1571-7. PubMed ID: 15257181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
    Banday AA; Lokhandwala MF
    Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.